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Abstract 
Antibodies to gliadin, a component of gluten, have frequently been reported in schizophrenia 
patients, and in some cases remission has been noted following the instigation of a gluten 
free diet. Gliadin is a highly immunogenic protein, and B cell epitopes along its entire 
immunogenic length are homologous to the products of numerous proteins relevant to 
schizophrenia (p = 0.012 to 3e-25). These include members of the DISC1 interactome, of 
glutamate, dopamine and neuregulin signalling networks, and of pathways involved in 
plasticity, dendritic growth or myelination.  Antibodies to gliadin are likely to cross react with 
these key proteins, as has already been observed with synapsin 1 and calreticulin.  Gliadin 
may thus be a causative agent in schizophrenia, under certain genetic and immunological 
conditions, producing its effects via antibody mediated knockdown of multiple proteins 
relevant to the disease process. Because of such homology, an autoimmune response may 
be sustained by the human antigens that resemble gliadin itself, a scenario supported by 
many reports of immune activation both in the brain and in lymphocytes in schizophrenia.   
Gluten free diets and removal of such antibodies may be of therapeutic benefit in certain 
cases of schizophrenia. 
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Introduction 
A number of studies from  China, Norway, and the USA have reported the presence of 
gliadin antibodies in schizophrenia 1-5. Gliadin is a component of gluten, intolerance to which 
is implicated in coeliac disease 6. Both gluten intolerance and coeliac disease have  also 
been associated with schizophrenia  7, 8, and remission of schizophrenia, in specific subsets 
of patients , has occasionally been reported following the instigation of a gluten-free diet 9, 10. 
Gliadin is a polyglutamine repeat protein (Fig 1), and de facto, a homologue of the mutant 
polyglutamine proteins in Huntington’s disease, Dentatorubropallidoluysian atrophy (DRPLA) 
, spinal and Bulbar Muscular Atrophy (Kennedy disease) and Spinocerebellar ataxias 11. 
Gliadin antibodies have also been found in Huntington’s disease and spinocerebellar ataxias 
and gluten per se has been associated with various forms of ataxia 12 13. These studies may 
implicate gliadin in the pathology of these diseases. This is not the subject of this article. 
As reported below, polyglutamine repeats are highly immunogenic, the more so with each 
addition of glutamine. A number of schizophrenia susceptibility gene products contain 
polyglutamine repeats, while others also display a high degree of homology to other regions 
of gliadin. Gliadin antibodies may thus play a role in the pathology of schizophrenia by cross-
reactive targeting of key schizophrenia-related proteins. 
 
Results  
Gliadin is a polyglutamine (polyQ) repeat protein with an internal contiguous sequence of 22 
glutamines (Fig 1). Gliadin is highly immunogenic and 181/296 (61%) of its residues are 
considered as B cell epitopes with the server-defined cut off index of 0.35 (Fig 2). 
http://www.polygenicpathways.co.uk/gliadin.htm. Polyglutamine repeats are also 
immunogenic, and all are above the threshold of 0.35 (Fig 2). The antigenicity increases with 
the number of glutamine repeats. The BLAST of gliadin (whole protein) versus the human 
proteome yielded 29 significant results, again including highly relevant proteins, many, but 
not all, influenced by the polyglutamine repeat (Table 1). These proteins belong to members 
of the DISC1 interactome and also include pre- and postsynaptic proteins related to 
glutamate, GABA, and neuregulin signalling. They are also involved in dopaminergic 
function, myelination, and dendritic spine development and to neurogenesis, inflammation 
and oxidative stress (Fig 3). 
 A more detailed analysis revealed an interesting type of homology that is common to many 
more proteins than are listed in Table 1. This is exemplified in Fig 4. The Clustal alignment of 
KCNN3 with gliadin shows a non-extensive homology with 18% amino acid identity shared 
by the two proteins, within the homologous region. The gliadin protein is characterised by 
many short repeat motifs, other than polyglutamines. These include (PQPQP) *4 ;(PQPQ) 
*5; (QPQP)*5;  (PQQP)*2; (QQPY)*2; (QPQPQ)*2;  (QQQQF)*2 and (VLQQ)*2. Some of 
these motifs can also be found in the KCNN3 protein, which, with the polyglutamine repeat 
contains 9 such areas of identity, many concentrated in a 13 amino acid contiguous 
tridecapeptide (QPQPPQLQQQQ). The overall gliadin/KCNN3 identity including these 
contiguous peptides is 5.3%. However, these matching gliadin/KCNN3 motifs extend over 
the whole length of the gliadin protein, which displays 31% identity with these KCNN3 
fragments. 
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These fragments are mostly (12/15) within highly immunogenic regions of the gliadin protein. 
Because this immunogenicity extends over many different regions, several different 
antibodies to gliadin or to its partially digested fragments are likely to be produced. These 
repeat motifs and their presence in human proteins are likely to dramatically increase the 
likelihood of cross-reactivity between gliadin, gliadin fragments and human antigens. 
These areas in human proteins were identified by sequential BLASTS of contiguous 25 
amino acid fragments, along the length of the gliadin protein, each BLAST overlapping by 5 
amino acids. By plotting these homologues along the length of the gliadin protein, these 
multiple repeats and their antigenicity could be identified simultaneously. In all, a total of 459 
human proteins contain at least one of these tetrapeptide matches, 60 with pentapeptide 
matches, and others with longer contiguous matches as shown in Table 2. 
This procedure allowed the definition of the number of gliadin matches within each human 
protein, and of the antigenic index of each of these matches. These results, for 5 or more 
matches are shown in Table 3: FOXP2, SMARCA2, NUMBL, KCNN3, and RAI1 contain 
from 14 to 22 of such matches. Certain key gene products including DISC1, neuregulin 2, 
dysbindin and synapsin 2 contain 5 or more of these gliadin consensus sequences. In fact, 
of the 459 proteins identified, 158 (34%) are the products of genes listed as susceptibility 
candidates in association studies. (See http://www.polygenicpathways.co.uk/gliadin.htm for 
details)  An example of peptide matching to the antigenicity profile is shown in Fig 5 for 
KCNN3. This also allowed antigenicity mapping by family as shown in for glutamate related 
proteins or for myelin related proteins, many of which match gliadin in highly immunogenic 
regions (Fig 6). 
A number of autoantibodies have been reported in schizophrenia. Their targets include the 
dopamine (DRD2) 14, glutamate (GRIN1) 15, acetylcholine (CHRNA7) 16 and  opioid (OPRM1) 
receptors  17 , heat shock protein 60 (HSPD1) 18 and hsp90 (HSP90A1) 19,  MYC binding 
protein 2 (MYCBP2)  18 nerve growth factor (NGF)  20 and striatin (STRN) 21 all of which are 
homologous to gliadin, with MYCBP2 and striatin particularly well represented (Fig 7). Myc 
inhibits myelination, and is also involved in dendrite and synapse formation 22, 23. Striatin 
plays an important role in dendritic spine development 24. 
Discussion 
The high immunogenicity of gliadin, over almost its entire length, suggests that multiple 
antibodies could be formed by presentation of diverse antigens in different cellular and tissue 
compartments. Such antibodies might be produced to the entire protein, or to its partially 
digested fragments. The homology with key schizophrenia related proteins, often covering 
many regions of gliadin is striking and suggests that gliadin antibodies could also target 
these human proteins. Indeed 9 of the autoantigens reported in schizophrenia patient are 
homologous to gliadin. It has also been shown that gliadin antibodies cross react with 
calreticulin and synapsin 1 25, 26. Synapsin 1 was homologous to the particular gliadin tested 
(PQQQP, PQQP and PLQQ) while calreticulin was not. It was however homologous to 
gamma gliadins from Triticum aestivum and Triticum urartu (VPRD), Triticum monococcum 
(VRPD) and a related goat grass, Aegilops searsii (PVIQ). 
These homologous sequences are short, and in most cases, tetrapeptides, although higher 
degrees of homology were observed in many proteins (from 5 to 9 amino acids, not including 
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polyglutamine repeats (Table 2). Antibodies are quite capable of binding to such short 
epitopes 27. In addition the repeat motifs in gliadin have already been noted and are, per se, 
immunogenic 28. 
The key pathological features of schizophrenia include reduced dendritic spine density and 
synaptic poverty 29, deficits in myelination and oligodendrocyte cell loss 30, 31, impaired 
neuregulin signalling 32and imbalances in glutamate and dopamine neurotransmission 33. 
Many gene products covering these networks are homologous to gliadin. The DISC1 
network, connected to many of these areas34 is also clearly targeted by gliadin homologues 
(Fig 1).  
Antibodies are able to enter the brain via blood-brain barrier  transporters 35 and can also 
enter cells via a high affinity immunoglobulin receptor, tripartite motif-containing 21 (TRIM21) 
36. 
This suggests that antibody related protein knockdown, of multiple proteins relevant to 
schizophrenia could be a direct consequence of gliadin allergy. Many studies have reported 
evidence of immune activation in schizophrenia patients, both in the brain 37, 38 and in 
lymphocytes 39, 40, and autoimmune attack of certain cells may well explain some of the 
ongoing pathology of schizophrenia, for example oligodendrocyte  30 and grey matter loss 41. 
Following digestion, gliadin will be broken into peptide fragments that may also find 
their way into the brain via the circulation, and uptake via peptide transporters. As partial 
homologues of many relevant proteins, they may also be able to interfere with the signalling 
processes controlled by these proteins. Several pharmacological effects of gliadin or gluten 
have indeed been noted. For example gluten peptides have opioid activity 42: Gliadin 
peptides are also able to activate protein kinase A 43 and bind to the chemokine receptor 
CXCR3 44. They are also able to interfere with epidermal growth factor signalling in a number 
of cell lines 45 and activate nuclear factor kappa beta signalling in monocytes 46 . This type of 
homology with human proteins may apply to allergens in general, whose deleterious effects 
are not necessarily restricted to immune activation, but also to the possibility of interaction 
with a multitude of host proteins that they resemble.  
Similar protein matches are found in many proteins expressed by the viruses 
implicated in Alzheimer’s disease 47 or schizophrenia, and indeed these viral consensus 
sequences tend to be longer. For example hexapeptide identity between influenza viral 
proteins and several schizophrenia relevant proteins has been noted: These include reelin, 
neurexin 1-alpha and DISC1 48. In fact several hundred schizophrenia susceptibility gene 
products display this type of homology to diverse viruses and parasites (T.Gondii and B. 
Burgdorferri) implicated as risk factors in schizophrenia. It has recently been shown that 
DNA from many common non-retroviral viruses is integrated into mammalian genomes 49. 
BLAST analyses of the human proteome also shows that thousands of human proteins 
contain these viral (or in this case allergen) contiguous matching sequences.  Indeed this 
type of viral homology appears to cover the entire human genome. (See 
http://www.polygenicpathways.co.uk/blasts.htm ). The human proteome has been estimated 
to contain ~33869 proteins with an average length of 375 amino acids 50. For pentapeptide 
matches, this yields a figure of 370*33869 potential matching blocks (12.53 million). These 
building blocks are identical to those in viral, bacterial, fungal and allergen proteins. Upon 
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infection or ingestion, these pathogenic proteins are likely to seed havoc in the panoply of 
the host’s signalling networks via the mechanisms described above, and are likely to 
contribute to the pathology of many human diseases. 
It should also be noted that the viral and allergen protein homology is of course reflected at 
the DNA level and that viral double stranded DNA, plant or bacterial DNA is indistinguishable 
from our own. It is thus plausible that many gene association studies, using blood samples, 
have been indexing infection and ingestion as well as identifying key susceptibility genes. 
This is less of a problem when using long DNA probes and in no way detracts from the gene 
association results, whose relevance is generally supported by a plethora of experimental 
data related to the function of the genes identified. However, the confluence of gene and risk 
factor homology suggests that many genes are risk factors precisely because they encode 
for proteins that are homologous to those expressed by the viral, bacterial and allergen risk 
factors. However, they may only act as risk factors when such confluence is achieved, 
perhaps explaining the problems of replication in both gene and risk factor association 
studies.   
Clearly gliadin, a major dietary component, cannot cause schizophrenia in all cases.  Gluten 
intolerance and gliadin allergy are evidently related to the immune system. Many immune 
related susceptibility genes (few of which were encountered in this study) have been 
reported in association studies, including genome-wide association studies 51. The high 
proportion of other types of schizophrenia susceptibility gene products related to gliadin 
suggests that those genes that encode for proteins with gliadin homology may be considered 
as risk factors if and when their products are homologous to a particular form of gliadin. 
Many different forms of gliadin, from diverse plant and bacterial species exist, as do many 
polymorphic genes, and their resultant differing protein sequences. The marriage of genes 
and risk factors, and the status of our immune system are thus three variables whose 
convergence may be obligatory to initiate the processes described above. 
Gliadin antibodies and gluten intolerance have often been associated with schizophrenia, 
and in some cases a gluten free diet has been reported to evoke the remission of symptoms 
(see introduction).  These data suggest that this is more than a simple association and that 
gliadin antibodies could well be the causative agent of schizophrenia in genetically and 
immunologically compromised individuals, and illustrate how this might be achieved. If so, 
then the instigation of a gluten free diet, as already shown 9, 10, may be an effective 
substitute for drug related interventions. However in certain cases, even if gliadin is 
removed, the homologous human proteins might well be able to sustain the production of 
further antibodies, due to the permanence of autoantigens in the human biological network. 
Antigen and antibody removal by immunoadsorption techniques, or immunosuppression, 
might thus prove to be effective therapies. Ways of identifying the subsets of patients, who 
might benefit from such strategies, including routine antibody detection, may have a marked 
effect on the prevalence and severity of schizophrenia. 
 
Acknowledgements: I would like to thank the many authors who have provided reprints and 
encouragement. 
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Methods. 
Gliadin is a polyglutamine (polyQ) repeat protein with an internal stretch of 22 glutamines. 
This sequence as well as gliadin or gliadin internal fragments were screened against the 
human proteome using the filters “schizophrenia”, “glutamate”, “dopamine” or “myelin” to 
trawl for proteins that might be related to gliadin (BlastP)52. Without these filters, many other 
polyglutamine proteins (Huntingtin, ataxins, the androgen receptor etc.) masked any 
underlying results. B-Cell epitopes within the gliadin protein were identified using the 
BepiPred server http://www.cbs.dtu.dk/services/BepiPred/, which predicts antigenicity 
related to the charge and hydrophobicity properties of the peptide 53. The BLAST results and 
supplementary data can be visualised at http://www.polygenicpathways.co.uk/gliadin.htm 
where a NextBio highlighting tool provides details for all gene symbol abbreviations. 
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Table 1  
Polyglutamine repeat proteins or proteins with significant overall homology to gliadin (BlastP 
gliadin vs. “schizophrenia”, “glutamate”, “dopamine” or “myelin”). Brief descriptions of 
function are provided for each protein. The number of glutamines is represented by, for 
example, Q22, or by the Q containing sequence in the human protein. E values are provided 
for the BLAST: If none is shown, the results were not significant (P> 0.05)  
Proteins QN and /or BLAST E value  
Glutamate and transmission 
GRINA | 
glutamate 
receptor, 
ionotropic, N-
methyl 
D-aspartate-
associated 
protein 1 
E value 2e-11 Uncharacterise
d glutamate 
binding NMDA 
receptor 
subunit 
GRIN3B | 
glutamate 
receptor, 
ionotropic, N-
methyl-D-
aspartate 
3B 
Q7 NMDA receptor 
subunit 
expressed in 
the human 
hippocampus 
and neocortex 
54 
GRM1 | 
glutamate 
receptor, 
metabotropic 
1 
Q5 Metabotropic 
glutamate 
receptor 
IQSEC2 | IQ 
motif and 
Sec7 domain 
2 
No polyglutamines 
BLAST E value   0.016 
Part of the 
post-synaptic 
density, binding 
to psd95 
(DLG4) 55 
NOS1AP : 
nitric oxide 
synthase 1 
(neuronal) 
adaptor 
protein 
HHQMQLLQQLLQQQQQQTQ Plays a role in 
both 
presynaptic 
and 
postsynaptic 
(NMDA) 
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glutamatergic 
function and 
controls 
dendritic spine 
development 56, 
57 
RIMS2 : 
regulating 
synaptic 
membrane 
exocytosis 2 
QQFEMYKEQVKKMGEESQQQQEQ Regulates  
calcium 
dependent 
neurotransmitte
r release 58 
SYN3 : 
synapsin III 
QQRLSPQGQQPLSPQSGSPQQQ Presynaptic 
protein 
regulating 
neurotransmitte
r release 59 
GRIPAP1 | 
GRIP1 
associated 
protein 1 
QQQQQEQEEALKQ- Part of the 
postsynaptic 
scaffold for 
glutamate 
(AMPA) 
receptors 60 
MAP1A : 
microtubule-
associated 
protein 1A 
QQTHEQQQQ   Part of the 
NMDA receptor 
postsynaptic 
density, that 
controls 
dendrite 
branching and 
synapse 
formation 61; 
Binds to 
postsynaptic 
density 
proteins that 
connect to 
NMDA Kainate 
, AMPA and 
ERBB 
receptors 
SPTAN1 : 
spectrin, 
alpha, non-
QQQQ Part of the 
postsynaptic 
density that 
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erythrocytic 1 
(alpha-fodrin) 
regulates 
glutamate 
receptor 
signalling 62 
RORB : RAR-
related orphan 
receptor B 
QKHQQRLQEQRQQQ  Little is known 
about this 
protein: 
However it 
binds to MAP6,  
a microtubule 
protein that 
controls 
synaptic 
organisation, in 
particular of 
glutamatergic 
synapses 
where it 
controls the 
expression of 
the glutamate 
transporter and 
presynaptic 
genes , 
synaptophysin 
and GAP-43 ,  
spinophilin and 
MAP2 63.  
Gamma amino butyric acid (GABA) related 
ATF5 cyclic 
AMP-
dependent 
transcription 
factor ATF-5  
No polyglutamines  
0.008 
Regulates the 
development of 
neurones, 
astrocytes and 
oligodendrocyt
es 64 
DGCR6 : 
DiGeorge 
syndrome 
critical region 
gene 6 
QKHQEAQQACRPHNLPVLQAAQQ 
 
BLAST E value  0.001 
Little is known 
except that is 
binds to the 
GABA-b 
receptor 
GABBR1 65 
SP4 : Sp4 
transcription 
QNAQDQSNSLQQVQIVGQPILQQIQIQQPQQQ Regulatesgluta
mate 
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factor  
BLAST E = 9e-05 
(GRIN2A), 
GABA 
(GABRA4) 
receptors (and 
many others): 
Also controls 
dendritic 
function 66-68 
Dopamine and serotonin  related 
FOXP2 
Forkhead box 
P2 
Q22 
BLAST  3e-25 
 
Controls 
pathways 
involved in 
embryonic and 
nervous-
system 
development, 
neurogenesis, 
cell migration 
and cell death. 
FOXP2 
knockout mice 
have lower 
cerebral 
dopamine 
concentrations. 
Expressed in 
dopamine and 
cyclic 
adenosine 
3',5'-
monophosphat
e-regulated 
phosphoprotein 
containing 
neurones in the 
cerebral cortex 
FOXP2 also 
controls 
dendritic spine 
development  
and synaptic 
plasticity. 69-72 
LMX1A : LIM 
homeobox 
QQQQQQDQQ  LMX1A and B 
control the 
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transcription 
factor 1, alpha 
development of 
midbrain 
dopamine 
neurones 73  LMX1B : LIM 
homeobox 
transcription 
factor 1, beta 
HQQQQE QQ 
KCNN3 
potassium 
intermediate/s
mall 
conductance 
calcium-
activated 
channel, 
subfamily N, 
member 3 
Q19 
BLAST E Value: 2e-22 
Regulates the 
activity of 
dopamine and 
serotonin 
neurones and 
plays a role in 
glutamate-
mediated long 
term 
potentiation 74, 
75 
MAGEL2 
MAGE-like 
protein 2  
QQAQASGPQ 
BLAST E Value 2e-05 
 
MAGEL2 and 
necdin bind to 
FEZ1 and are 
involved in the 
control of 
axonal growth 
and in the 
development of 
brain 
dopamine, 
serotonin and 
noradrenaline 
neurones 76 
NALCN : 
sodium leak 
channel, non-
selective 
QQQSCSIIHSLRESQQQE Sodium 
channel 
activated by 
reducing 
extracellular 
calcium levels: 
It is activated 
by substance P 
and 
neorotensin in 
ventral 
tegmental and 
hippocampal 
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neurones 77 
PDCD6IP 
programmed 
cell death 6 
interacting 
protein 
E value 6e-06 Apoptosis 
inhibitor that 
also binds to 
D1 and D3 
dopamine 
receptors 78 
POU3F2 POU 
class 3 
homeobox 2  
brain-specific 
homeobox/PO
U domain 
protein 2 
Q18 
E value = 4e-15 
Controls the 
expression of 
neural 
progenitors and 
of the 
tryptophan 
hydroxylase 
gene (TPH2) 79, 
80 
PPP1R3F : 
protein 
phosphatase 
1, regulatory 
(inhibitor) 
subunit 3F 
QQQQLPQLEPQ Protein 
phosphatase 1 
regulates the 
activity of many 
transmitter 
systems 
(glutamate, 
GABA, 
dopamine . 
serotonin, inter 
alia ): It also 
modifies 
dendritic spine 
development . 
81-86 
RANBP9 | 
RAN binding 
protein 9  
Q8 Binds to the D1 
dopamine 
receptor as 
well as to nerve 
growth factor 
receptors 
NGFR and trkB 
(NTRK2) , 
androgen and 
glucocorticoid 
receptors and 
DISC1 87-91  
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SMARCA2 : 
SWI/SNF 
related, matrix 
associated, 
actin 
dependent 
regulator of 
chromatin, 
subfamily a, 
member 2 
Q2 
BLAST E value 3e-15 
Binds to the 
promoter of the 
noradrenaline 
transporter 
SLC6A2 : It 
also controls 
neuronal 
development 
on the mid 
hindbrain 92, 93  
SMARCC1 : 
SWI/SNF 
related, matrix 
associated, 
actin 
dependent 
regulator of 
chromatin, 
subfamily c, 
member 1 
QQMEQQQHGQNPQQAHQH  
And 
EQQRQQLLTERQNFHMEQLKYAELRARQQMEQQQHG
QNPQQ 
 
Regulates the 
function of the 
glucocorticoid 
receptors 
(NR3C1), and 
Nurr77 
(NR4A1) 94 
both of which 
play an 
important role 
in the control of 
dopamine 
neurones 95  
Neuregulin , NOTCH and growth 
NRG2 : 
neuregulin 2 
QQQQQQREEQQQQQQQQRERQQQQEQQQ This particular 
neuregulin is 
localised to 
dendrites and 
controls the 
expression of 
DISC1 ; It also 
controls free 
radical release 
from microglia 
96-98 
NUMBL numb 
homolog 
(Drosophila)-
like 
Q20 
BLAST E value 6e-13 
Important 
regulator of 
cortical 
neurogenesis 
99, 100 
RAI1 retinoic 
acid induced 1 
Q14 Regulates 
BDNF 
expression and 
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BLAST E Value = 4e-10 also regulates 
autoimmunity 
by inhibiting 
lymphocyte 
activation and 
and triggen 
receptor 
signalling 101, 102
Dendritic spines and plasticity 
HDAC4 : 
histone 
deacetylase 4 
QQQHQQFLEKHKQQFQQQQLQ 
BLAST E value  0.006 
Histone 
deacetylases 
regulate  gene 
transcription by 
modifying 
histones. 
HDAC4 is 
localised in the 
brain and 
shuttles 
between the 
nucleus and 
cytoplasm in 
response to 
neuronal 
activity. 
HDAC4 is also 
localised in 
dendritic spines 
associated with 
the 
postsynaptic 
density: 
HDAC9 also 
shuttles from 
nucleus to 
cytoplasm in 
response to 
neuronal 
activity, and 
controls 
dendritic spine 
density 103-105 
HDAC5 | 
histone 
deacetylase 5 
QQQEMLAAKQQQEMLAAKRQQELEQQRQREQQRQ
EELEKQRLEQQ 
 
BLAST E value  5e-05 
HDAC9 : 
histone 
deacetylase 9 
QQQQQIQKQLLIAEFQKQHENLTRQHQAQLQEHIKLQQ
ELLAIKQQQ 
 
MCF2 : 
MCF.2 cell 
QQDQLTERDKFQISLQQNDEKQQ Controls 
dendritic spine 
15 
 
line derived 
transforming 
sequence 
development 
106 
MED25 | 
mediator 
complex 
subunit 25 
VQQQ 
BLAST E Value   0.001 
 Regulates the 
retinoid 
receptor RAR , 
which controls 
dendritic spine 
formation, 107 
NR4A3 : 
nuclear 
receptor 
subfamily 4, 
group A, 
member 3 
also known as 
nor-1 
QQQHQQ  
 
  Regulates 
pyramidal 
neurone 
survival and 
hippocampal 
axon guidance 
and controls 
neurite 
extension  108, 
109 
PURA : 
purine-rich 
element 
binding 
protein A 
EQLHQQQQQQQEE 
BLAST E value    0.014 
A single 
stranded DNA 
(e.g. viral) 
binding protein 
involved in the 
transport of 
RNA to 
dendrites. 
Plays and 
important role 
in postnatal 
brain 
development 
and also 
controls the 
transcription of 
myelin basic 
protein in 
oligodendrocyt
es 110-112 
Myelin related 
FOXJ3 | 
forkhead box 
QQQP Involved in 
godendrocyte 
16 
 
J3 BLAST E value 5E-0.5 
 
oliferation  113 
NCOR2 | 
nuclear 
receptor 
corepressor 2 
Q17 
BLAST E value = 6E-11 
Controls 
thyroid 
hormone, 
retinoic acid 
and steroid 
receptors114. 
Retinoids play 
a key role in 
dopamine 
function, 
dendritic spine 
development 
and 
oligodendrocyt
e differentiation 
115-117 
PEG10 | 
paternally 
expressed 10 
No Polyglutamines 
BLAST E value   0.006 
Controls the 
expression of 
myelin basic 
protein 118 
SGCE : 
sarcoglycan, 
epsilon 
QTQQNLPHQTQIPQQQ Sarcoglycans 
are typically 
associated with 
muscle cells: 
However 
SGCE is 
expressed in 
Schwann cells, 
and in 
monoaminergic 
neurones and 
is believed to 
regulate 
dopaminergic 
activity 119-121 
Development and neurogenesis 
DISC1 : 
disrupted in 
schizophrenia 
QQLRREIEEQEQQLQ Key “hub gene” 
connected to 
many 
schizophrenia 
17 
 
1 networks 34 
MACF1 : 
microtubule-
actin 
crosslinking 
factor 1 
QLQQLQSQLAHQTEQKTLQKQQNTCHQQ MACF1 
knockdown 
impairs cortical 
and other brain 
area  
development : 
It also plays a 
role in growth 
cone advance 
122, 123 
PCM1 : 
pericentriolar 
material 1 
QQQQRELKQLQEE Involved in 
neuronal 
migration and 
neurogenesis 
124 
PCNT : 
pericentrin 
QQQALHSQQQ Regulates the 
neuronal 
progenitor cells 
in the 
developing 
cortex 125 
SEL1L3 : sel-
1 suppressor 
of lin-12-like 3 
QQQQQ Little is known, 
except that 
SEL1L3 binds 
to tubulin 
TUBB3 which 
is involved in 
cortical 
development 
and neuronal 
migration  126 
Endocytosis 
CHERP | 
calcium 
homeostasis 
endoplasmic 
reticulum 
protein 
Q12 
BLAST E value   7e-08 
No data: 
Endoplasmic 
reticulum 
location 
CLINT1 : 
clathrin 
QQQNMQQ Involved in 
clathrin 
18 
 
interactor 1 mediated 
endocytosis 
and the 
endosomal 
transport of 
SNARE 
proteins 
including STX7 
127 
STX7 : 
syntaxin 7 
QQLQQKQQ Involved in 
endosomal to 
lysosomal 
traffic and in 
phagocytosis. 
Also expressed 
in neutrophils 
and 
macrophages 
128-131  
Apoptosis and oxidative stress 
EP400 | E1A 
binding 
protein p400 
Q22  
BLAST E value 1E-16 
Involved in the 
regulation of 
oxidative stress 
132 
HIPK3 : 
homeodomain 
interacting 
protein kinase 
3 
QQKLTSAFQQQH Involved in the 
Fas apoptosis 
pathway, and 
also controls 
the  expression 
of cytochrome 
p450 CYPA11, 
the enzyme 
responsible for 
pregnelonone 
synthesis, the 
firsts step in 
steroid 
hormone 
production 133, 
134 
SETD2 : SET 
domain 
containing 2 
QREAQKQQQQMQ    Involved in 
embryonic 
vascular 
19 
 
(a histone 
methyltransfer
ase) 
development 
135 
SHISA5 
protein shisa-
5 precursor  
No polyglutamines  
BLAST E value   e-04 
Localised in the 
endoplasmic 
reticulum and 
nuclear 
membrane and 
involved in p53 
and p73 
mediated 
apoptosis 136-138 
TFAP4 | 
transcription 
factor AP-4  
E value 0.002 AP4 controls 
the expression 
of p21 a cell 
cycle cyclin 
dependent 
kinase inhibitor 
induced by p53 
139  
Immune system 
HLX | H2.0-
like homeobox 
Q8  
BLAST E value    6e-06 
Regulates 
interferon 
gamma 
production in 
natural killer 
cells 140 
HOXA10 | 
homeobox 
A10 
PPQQQPPPPPQP 
E value  0.012 
Part of a 
vitamin D3 
dependent 
pathway 
regulating 
haematopoesis 
141 
ITIH4 : inter-
alpha 
(globulin) 
inhibitor H4 
(plasma 
Kallikrein-
sensitive 
QQQKSPEQQE Acute phase 
protein 
involved in 
inflammatory 
processes 142 
20 
 
glycoprotein) 
NFAT5 | 
nuclear factor 
of activated T-
cells 5, 
tonicity-
responsive 
Q17 
BLAST E value  1e-16 
 
Plays an 
important role 
in the immune 
system and in 
water  
homoeostasis : 
Polydipsia 
(excessive 
water drinking) 
and water 
imbalance 
have been 
observed in 
schizophrenia 
143, 144. 
Translation initiation 
ABCF1 | ATP-
binding 
cassette, sub-
family F 
(GCN20), 
member 1 
Q10 BLAST  
E value  9E-04 
Regulates 
translation 
initiation 145 
EIF4G3 | 
eukaryotic 
translation 
initiation factor 
4 gamma, 3 
No polyglutamines 
BLAST E value   0.008 
Translation 
initiation factor 
Miscellaneous 
ALX4 | ALX 
homeobox 4 
Q4 
BLAST E value 9e-08  
Involved in 
cranial bone 
development 66, 
67, 109, 146, 147 
ARID3B | AT 
rich interactive 
domain 3B 
(BRIGHT-like) 
Q11  
BLAST E value    1e-05 
No data 
PHC2 | 
polyhomeotic 
homolog 2 
VIQQQPQPQQQQPPPQQ 
BLAST E value  6E-0.6 
No data 
21 
 
 
 
 
Table 2 Proteins with hexapeptide, or greater, matches to the gliadin protein. The consensus 
sequence is shown on the left followed by the gene symbols. N is the number of contiguous 
amino acids : DISC1 (N=5) is included for interest: Q = glutamine, followed by the number of 
Q’s e.g. Q22.  Full tables with abbreviations and data provided by a NextBio highlighting 
service are available at http://www.polygenicpathways.co.uk/gliadin.htm 
 
Sequence and Gene symbol N
Q22 FOXP2 SMARCA2 22
Q20 NUMBL 20
Q19 KCNN3 19
Q18 POU3F2 18
Q14 RAI1 14
TAVR-PVP PRODH (Proline dehydrogenase) 9
Q8 NRG2 8
LQQ-QQQ NOS1AP KCNN3 7
PSS --SLQQ ZDHHC8 (Zinc finger protein) 7
Q7 PURA 7
QP+RQVP FXR1 (Fragile X protein) 7
FPPQ+P CABIN1  (calcineurin binding protein) 6
P+PQQP SYN2 6
PQPQPQ PHLDA1 MYST3 (histone acetyltransferase) 
CPEB2 (cytoplasmic polyadenylation element binding 
protein) 
6
PYPQPP SHISA5  6
Q6 LMX1A NOS1AP 6
QILQQQ FOXP2 6
QPQPQP MEF2A (myocyte enhancer factor) MED12L 
(Mediator complex) 
6
Q-QGSV GRIP1(glutamate receptor interacting 
protein) 
6
QQLCCQ SNX6 (sorting nexin) 6
QQPPQQ SMARCA2 6
QQPQQQ SP4 6
Q-QQLP DTNBP1 (Dysbindin) 6
QSGV-P MAP6 6
Q-SLQQ SLC1A6 (glutamate transporter) SQVS 
ABCA13 GABRA6 (GABA receptor) 
6
QUAQGS SLC25A14 (mitochondrial carrier, brain) 6
SSQVSL PIK3C2G (phosphatidylinositol 3-kinase) 6
VQPQQ STRN 6
LQLQP DISC1 5
22 
 
 
 
 
 
Table 3 
The number of gliadin matches (tetrapeptide or more) within human proteins 
 
 
GENE SYMBOL  N 
MACF1 24 
ATP2A2 21 
ANK3 19 
RAI1 17 
KCNN3, SMARCA2 15 
SETD2, SP4, STAB1 14 
ABCA13, NUMBL, SYN3 13 
ADAM12, ATF7IP 12 
ASTN1, BTN3A2, KIF13A, MED25,PCNT,  
PLXNA2, SPTAN1 
11 
CCDC141, CIT, FOXP2, RIMS2 10 
ABCA7, CABIN1, MAGEL2, MAP1A, 
MAP6,MYCBP2,  PPP1R3F 
9 
 
ATF5, EPB41L1, MYO1D, NR4A3, PCM1, 
RELN 
8 
CLINT1, HDAC9, ITIH4, KCNH5, LMX1B, 
MMS22L, SELIL3, SEMA3D, SPTNB4, SYN2, 
UTRN 
7 
7 
DNAJC6, HDAC10, LMX1A, POM121L2, 
RAPGEF6, SIM1, SMARCC1 
6 
ANK2, BAP1, BRD1, CACNA1B, CDC42SE2, 
CELF4, DISC1, EGR4, FNIP1, FUBP1, 
GPR125, GRIP1, HIPK3, MDGA1, NALCN, 
NCS1, NOTCH4,, TMEM200C 
5 
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Fig 1: The sequence of the gliadin protein used in this study: Polyglutamine or other repeat 
sequences are highlighted in bold or in grey. 
 
Fig 2: 
Top: 
The B cell epitope index values of the gliadin protein (amino acid 1-276) as predicted by the 
Bepipred server. The cut-off value of 0.35 is illustrated by the thick horizontal line.  
Bottom 
The B cell epitope indices for various glutamine repeats (QQQ) * 1-7 
 
Fig 3  
An interactome network for the proteins identified in this study. Proteins in grey boxes show 
a significant degree of homology with gliadin in the BLAST analyses, or are polyglutamine 
repeat proteins. Linked boxes represent binding between two components; these data were 
gleaned from the protein interaction section of Entrez Gene. Arrows indicate other effects on 
transcription or other functional effects. See Table 1 for details. 
 
Fig 4  
A) Clustal line up between gliadin and the potassium channel, KCNN3 
B) Gliadin consensus sequences with the KCNN3 protein 
C) KCNN3 consensus sequences within the gliadin protein 
 
Fig 5 
The B cell epitope index for KCNN3 sequences within the gliadin protein. Other human 
proteins trapped in passing are also shown. 
Fig 6  
The B cell epitope indices for sequences of glutamate (top)  and myelin related proteins 
(bottom) sharing consensus sequences with gliadin. 
Fig 7 
The B cell epitope indices for sequences of schizophrenia-related autoantigens sharing 
consensus sequences with gliadin. 
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>gi|100783|pir||A27319 gliadin - wheat Q =glutamine 
MKTFLILALLAIVATTATTAVRV PVPQPQPQNPSQPQPQRQVPLVQQQQFPGQQQQFPP QQPYPQPQPFP 
SQQPYLQLQPFPQPQPFPPQLPYPQPPPFSPQQPYPQPQPQYPQPQQPISQQQAQQQQQQQQQQQQQQQ
QQQILPQILQQQLIPCRDVVLQQHNIAHARSQVLQQSTYQPLQQLCCQQLWQIPEQSRCQAIHNVVHAIIL 
HQQQQQQQPSSQVSLQQPQQQYPSGQGFFQPSQQNPQAQGSVQPQQLPQFEEIRNLALQTLPRMCNVYIP 
PYCSTTTAPFGIFGTN 


Gliadin   MKTFLILALLAIVATTATTAVRVPVPQPQPQNPSQPQPQRQVPLVQQQQFPGQQQ--QFP  58 
KCNN3     MDTSGHFHDSGVGDLDEDPKCPCPSSGDEQQQQQQQQQQQQPPPPAPPAAPQQPLGPSLQ  60 
          *.*   :   .:      .    * .  : *: .* * *:* *       * *    .:  
Gliadin   PQQPYPQPQPFPSQQPYLQLQPFP-------QPQPFPPQLPYPQPPPFSPQQPYPQPQPQ  111 
KCNN3     PQPPQLQQQQQQQQQQQQQQPPHPLSQLAQLQSQPVHPGLLHSSPTAFRAPPSSNSTAIL  120 
          ** *  * *   .**   *  *.*       *.**. * * :..*..* .  .  ..    
Gliadin   YPQPQQPISQQQAQQQQQQQQQQQQQQ------QQQQILPQILQQQLIPCRDVVLQQHN-  164 
KCNN3     HPSSRQGSQLNLNDHLLGHSPSSTATSGPGGGSRHRQASPLVHRRDSNPFTEIAMSSCKY  180 
          :*..:*  . :  ::   :. ..   .      :::*  * : :::  *  ::.:.. :  
Gliadin   -----------IAHARSQVLQQSTYQPLQQLCCQQLWQIPEQSR---CQAIHNVVHAIIL  210 
KCNN3     SGGVMKPLSRLSASRRNLIEAETEGQPLQLFSPSNPPEIVISSREDNHAHQTLLHHPNAT  240 
                      *  *. :  ::  **** :. .:  :*  .**         : *.    
GliadinHQQQQQQQPSSQVSLQQPQQQYPSGQGFFQPSQQNPQAQG--------------------  250 
KCNN3     HNHQHAGTTASSTTFPKANKRKNQNIGYKLGHRRALFEKRKRLSDYALIFGMFGIVVMVI  300 
*::*:   .:*..:: :.:::  .. *:    ::    :                      
Gliadin-SVQPQQLPQFEEIRNLALQTLPRMCNVYIP----PYCSTTTAPFGIFGTN---------  296 
KCNN3   ETELSWGLYSKDSMFSLALKCLISLSTIILLGLIIAYHTREVQLFVIDNGADDWRIAMTY  360 
:  .  * . :.: .***: *  :..: :     .* :  .  * * .    
 
Identities= 54/300 = 18% 
 
B)Tetrapeptide or greater gliadin consensus sequences within the KCNN3 
protein 
 
>gi|116805330|ref|NP_002240.3| small conductance calcium-activated potassium channel protein 
3 isoform a [Homo sapiens] 
MDTSGHFHDSGVGDLDEDPKCPCPSSGDEQPPPPAPPAAPQQPLGPSLQPQPPQLQQQQQQQQQQQQQQ 
PPHPLSQLAQLQSQPVHPGLLHSSPTAFRAPPSSNSTAILHPSSRQGSQLNLNDHLLGHSPSSTATSGP 
GGGSRHRQASPLVHRRDSNPFTEIAMSSCKYSGGVMKPLSRLSASRRNLIEAETEGQPLQLFSPSNPPE 
IVISSREDNHAHQTLLHHPNATHNHQHAGTTASSTTFPKANKRKNQNIGYKLGHRRALFEKRKRLSDYA 
LIFGMFGIVVMVIETELSWGLYSKDSMFSLALKCLISLSTIILLGLIIAYHTREVQLFVIDNGADDWRI 
AMTYERILYISLEMLVCAIHPIPGEYKFFWTARLAFSYTPSRAEADVDIILSIPMFLRLYLIARVMLLH 
SKLFTDASSRSIGALNKINFNTRFVMKTLMTICPGTVLLVFSISLWIIAAWTVRVCERYHDQQDVTSNF 
LGAMWLISITFLSIGYGDMVPHTYCGKGVCLLTGIMGAGCTALVVAVVARKLELTKAEKHVHNFMMDTQ 
LTKRIKNAAANVLRETWLIYKHTKLLKKIDHAKVRKHQRKFLQAIHQLRSVKMEQRKLSDQANTLVDLS 
KMQNVMYDLITELNDRSEDLEKQIGSLESKLEHLTASFNSLPLLIADTLRQQQQQLLSAIIEARGVSVAV 
GTTHTPISDSPIGVSSTSFPTPYTSSSSC 
 
Identities= 38/720 5.3% 
 
C)KCNN3 matching contiguous sequences within the gliadin protein 
 
>gi:100783:pir::A27319 gliadin - wheat 
MKTFLILALLAIVATTATTAVRVPVPQPQPQNPSQPQPQRQVPLVQQQQFPGQQQQFPPQQPYPQPQPFPSQQPYLQLQPFPQPQPFPPQLPY
PQPPPFSPQQPYPQPQPQYPQPQQPISQQQAQQQQQQQQQQQQQQQQQQILPQILQQQLIPCRDVVLQQHNIAHARSQVLQQSTYQPLQQLCC
QQLWQIPEQSRCQAIHNVVHAIILHQQQQQQQPSSQVSLQQPQQQYPSGQGFFQPSQQNPQAQGSVQPQQLPQFEEIRNLALQTLPRMCNVYI
PPYCSTTTAPFGIFGTN 
 
Identities 94/296=32% 
a 



